Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease

Haematologica. 2020 Nov 1;105(11):2694-2697. doi: 10.3324/haematol.2020.253856.
No abstract available

MeSH terms

  • Anemia, Sickle Cell* / therapy
  • Hemolysis
  • Humans
  • Isoantibodies
  • Transfusion Reaction*

Substances

  • Isoantibodies